Linolelaidic acid (C18:2N6T) is one member of the CLAs that has been proved to play roles in body fat deposition (Park et al., 1997; Gaullier et al., 2004; Halade et al., 2010), tumor process (Wong et al., 1997; Ip et al., 2003; Shiraishi et al., 2010), and insulin resistance (Risérus et al., 2002, 2004). The gene discussed is INS; the disease is neoplasm.